1. Home
  2. DSX vs SGMT Comparison

DSX vs SGMT Comparison

Compare DSX & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.42

Market Cap

220.0M

ML Signal

HOLD

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$5.21

Market Cap

204.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
SGMT
Founded
1999
2006
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
204.2M
IPO Year
2005
2023

Fundamental Metrics

Financial Performance
Metric
DSX
SGMT
Price
$2.42
$5.21
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$27.00
AVG Volume (30 Days)
650.4K
800.4K
Earning Date
02-26-2026
03-11-2026
Dividend Yield
1.71%
N/A
EPS Growth
231.99
N/A
EPS
0.15
N/A
Revenue
$218,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.40
$125.00
P/E Ratio
$15.55
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$1.73
52 Week High
$2.39
$11.41

Technical Indicators

Market Signals
Indicator
DSX
SGMT
Relative Strength Index (RSI) 69.07 39.15
Support Level $2.17 $5.31
Resistance Level $2.33 $5.74
Average True Range (ATR) 0.10 0.52
MACD 0.00 -0.06
Stochastic Oscillator 95.32 8.70

Price Performance

Historical Comparison
DSX
SGMT

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: